Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LOHACO is a prominent Japanese e-commerce platform operated by ASKUL Corporation in strategic partnership with Z Holdings (SoftBank Group). Launched in 2012, the platform is designed around the Lifestyle of Health and Co-existence (LOHAS) concept, targeting urban consumers with a wide range of daily necessities. Within the healthcare sector, LOHACO is a major distributor of over-the-counter (OTC) pharmaceuticals, health supplements, and nursing care products. The company leverages ASKUL's advanced logistics network and Yahoo Japan's digital ecosystem to provide efficient, data-driven retail services. While LOHACO does not engage in primary drug discovery or biotechnology R&D, it serves as a critical commercial partner for life science companies looking to reach the Japanese consumer market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LOHACO.